The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 24, 2023
Filed:
Oct. 26, 2020
Applicant:
Shanghai Zhonghua Pharmaceutical Co., Ltd, Shanghai, CN;
Inventors:
Jiahua Jin, Shanghai, CN;
Biye Wang, Shanghai, CN;
Liqin Ding, Shanghai, CN;
Wujie Cao, Shanghai, CN;
Xiaoping Zhu, Shanghai, CN;
Tian Lan, Guangdong, CN;
Assignee:
Shanghai Zhonghua Pharmaceutical Co., Ltd, Shanghai, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 36/9068 (2006.01); A61P 1/16 (2006.01); A61K 31/045 (2006.01); A61K 36/28 (2006.01); A61K 36/484 (2006.01); A61K 36/534 (2006.01); A61K 36/54 (2006.01); A61K 36/61 (2006.01); A61K 36/67 (2006.01); A61K 36/79 (2006.01); A61K 36/899 (2006.01); A61K 36/9064 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/34 (2017.01); A61K 47/36 (2006.01); A61K 36/285 (2006.01); A61K 36/48 (2006.01); A61K 36/57 (2006.01);
U.S. Cl.
CPC ...
A61K 36/9068 (2013.01); A61K 31/045 (2013.01); A61K 36/28 (2013.01); A61K 36/285 (2013.01); A61K 36/48 (2013.01); A61K 36/484 (2013.01); A61K 36/534 (2013.01); A61K 36/54 (2013.01); A61K 36/57 (2013.01); A61K 36/61 (2013.01); A61K 36/67 (2013.01); A61K 36/79 (2013.01); A61K 36/899 (2013.01); A61K 36/9064 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/34 (2013.01); A61K 47/36 (2013.01); A61P 1/16 (2018.01);
Abstract
An application of Longhu Rendan in preparing a medicament for preventing and/or treating liver fibrosis. The Longhu Rendan has significant effect in improving fibrosis, and its effect in anti-liver fibrosis and liver protection is equivalent to those of a positive drug silybin.